SiliconSnark (Page 21)

Latest

SiliconSnark robot rolls a glowing drug-application binder outside a Waltham biotech campus.

Boston Tech

Cogent Filed Its Third Bezuclastinib NDA, and Waltham Looks Weirdly Inevitable

Waltham-based Cogent filed an NDA for bezuclastinib in advanced systemic mastocytosis, turning a rare-disease bet into a serious 2026 launch race.

SiliconSnark robot watches 8090's giant AI software factory process code, compliance logs, and funding money.

Startups

8090 Raised $135 Million to Turn Vibe Coding Into Enterprise Paperwork

8090 raised $135 million to bring AI coding into regulated enterprise workflows. Big ambition, real demand, serious controls, and a compute bill lurking in the walls.

SiliconSnark robot watches a volunteer under a giant brain-scanning helmet as AI decodes text in a research lab.

Meta Turns Brain Waves Into Text. The Helmet Still Deserves Top Billing.

Meta’s Brain2Qwerty decodes typed sentences from noninvasive brain signals. The science is real, the patient upside is real, and the helmet is not exactly AirPods.

SiliconSnark's robot stands in an AI data center guarding a giant power module after Reed Semiconductor's $100 million funding round.

Startups

Reed Semiconductor Raised $100 Million to Keep AI Servers From Browning Out

Reed Semiconductor's $100 million round says the AI boom is now financing power delivery. Annoying, essential, and far more strategic than it sounds.

SiliconSnark's robot reviews KapitalGPT inside a financial education arcade with credit, real estate, stock, and exam games.

Startups

KapitalGPT Turns Financial Education Into Games, Because Flashcards Had It Coming

KapitalGPT is gaming software for financial education, covering credit repair, real estate, stock market lessons, options, insurance, and FINRA exam prep.

The SiliconSnark robot holds a giant receipt at a data-center cash register as chips, GPUs, and a humanoid robot wait in line.

This Week in Snark

This Week in Snark: The GPU Mortgage Comes Due, Memory Becomes Money, and Robots Learn to Fear Paperwork

OpenAI flinched at its own IPO, Micron printed software margins on RAM, and the robots learned to fear a safety review. The AI bill has arrived.

SiliconSnark robot judges dirty dishes inside a cutaway dishwasher for the first Overkill article.

SiliconSnark Overkill

SiliconSnark Overkill: Dishwashers Turn Dirty Plates Into a Tiny Water-Pressure Courtroom

SiliconSnark Overkill begins with dishwashers: the hidden hydraulics, sensors, chemistry, and history behind the machine judging your plates.

SiliconSnark's robot reviews viz42 as messy specs become narrated architecture diagrams, dashboards, charts, and maps.

Startups

viz42 Turns Messy Specs Into Narrated Diagrams, Which Is the Better Pitch

viz42 turns messy specs, notes, files, and data into editable diagrams, dashboards, charts, maps, and narrated architecture walkthroughs.

SiliconSnark robot reacts to vivo's X Fold6 unfolding into a battery-heavy productivity showpiece.

vivo X Fold6 Stuffed a 7,000mAh Battery Into a Foldable and Called It Productivity

vivo's June 26 X Fold6 packs a 7,000mAh battery, Zeiss cameras, and big-screen multitasking into one foldable. Excessive? Absolutely. Tempting? Also yes.

SiliconSnark robot in a remittance counter turning cash transfers into digital dollar balances.

Fintech

MoneyGram Built a Stablecoin for Remittances and Kept the Cash Window Open

MoneyGram's MGUSD launch shows stablecoins growing up into remittance infrastructure, where cash-out, FX, and settlement timing matter more than crypto ideology.

SiliconSnark’s robot inspects Razer’s glowing Soma Chroma gaming chair in a neon streaming setup.

Consumer Tech

Razer Turned a Gaming Chair Into a 300-Game Light Show

Razer's $499.99 Soma Chroma adds reactive RGB to a gaming chair and somehow makes battlestation excess look almost thoughtful.

SiliconSnark robot in Kendall Square holding an mRNA-6007 vial as giant immune cells float above Cambridge labs.

Boston Tech

Moderna Put CAR-T in a Vial, and Cambridge Called It a Platform

Cambridge-based Moderna unveiled mRNA-6007, an in vivo CAR-T bet on lupus and related autoimmune disease that could make cell therapy less bespoke.

See all